EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Anticancer Activity of Ether Derivatives of Chrysin

Arkadiusz Sokal iD, Patryk Mruczek iD, Mateusz Niedoba iD, Agnieszka Dewalska iD, Klaudia Stocerz iD, Monika Kadela-Tomanek iD

Molecules · 19.02.2025 · 30 (4) · 960

DOI: 10.3390/molecules30040960 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 19.02.2025. Verfasst von Arkadiusz Sokal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 4 Jagiellońska Str., 41-200 Sosnowie…. Hauptthemen laut MEDLINE: Flavonoids, Antineoplastic Agents, Neoplasms, Ethers. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Project European Funds for Silesia 2021–2027.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chrysin, a naturally occurring flavonoid, exhibits a broad spectrum of biological activities, including showing anticancer properties. However, its clinical application is limited by poor bioavailability and low solubility. The introduction of an amine, amide, ester, or alkoxy group to a flavone skeleton influences the biological activity. This review also discusses hybrid compounds, such as the chrysin–porphyrin hybrid, which are characterized by higher biological activity and better bioavailability properties than single molecules. This review concentrates on the anticancer activity of chrysin and its derivatives against the most popular cancers, such as breast, lung, prostate, and gastrointestinal tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonoidsAntineoplastic AgentsNeoplasmsEthersHumansAnimalsMolecular Structure

Stichwörter der Autor:innen

anticancerchrysinchrysin derivatives

Substanzen

chrysinFlavonoidsAntineoplastic AgentsEthers

Autor:innen und Institutionen

  • Department of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 4 Jagiellońska Str., 41-200 Sosnowiec, Poland.
  • Doctoral School, Medical University of Silesia in Katowice, 15 Poniatowskiego Str., 40-055 Katowice, Poland.
  • Department of Pathology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 30 Ostrogórska Str., 41-200 Sosnowiec, Poland.
  • Department of Microbiology and Immunology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 19 Jordana Str., 41-800 Zabrze, Poland.
  • Department of Community Pharmacy, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 10 Jedności Str., 41-200 Sosnowiec, Poland.

ORCID-Profile: Arkadiusz Sokal, Patryk Mruczek, Mateusz Niedoba, Agnieszka Dewalska, Klaudia Stocerz, Monika Kadela-Tomanek

Förderung

  • Project European Funds for Silesia 2021–2027

Zitieren

APA

Sokal, A., Mruczek, P., Niedoba, M., Dewalska, A., Stocerz, K., & Kadela-Tomanek, M. (2025). Anticancer Activity of Ether Derivatives of Chrysin. Molecules, 30(4), 960. https://doi.org/10.3390/molecules30040960

Vancouver

Sokal A, Mruczek P, Niedoba M, Dewalska A, Stocerz K, Kadela-Tomanek M. Anticancer Activity of Ether Derivatives of Chrysin. Molecules. 2025;30(4):960. doi:10.3390/molecules30040960

BibTeX
@article{Sokal2025,
  author = {Sokal, Arkadiusz and Mruczek, Patryk and Niedoba, Mateusz and Dewalska, Agnieszka and Stocerz, Klaudia and Kadela-Tomanek, Monika},
  title = {Anticancer Activity of Ether Derivatives of Chrysin},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {4},
  pages = {960},
  doi = {10.3390/molecules30040960}
}
Kostenlos starten →